Response to the letter by Wang et al.: Selumetinib for plexiform neurofibroma: Advances and ongoing challenges.

IF 16.4 1区医学 Q1 CLINICAL NEUROLOGY

Neuro-oncology Pub Date : 2024-10-03 DOI:10.1093/neuonc/noae181

Beom Hee Lee, Hyery Kim, Hee Mang Yoon

引用次数: 0

查看原文本刊更多论文

回应 Wang 等人的信：赛鲁米替尼治疗丛状神经纤维瘤：进展与持续挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neuro-oncology 医学-临床神经学

CiteScore

27.20

自引率

6.30%

发文量

1434

审稿时长

3-8 weeks

期刊介绍： Neuro-Oncology, the official journal of the Society for Neuro-Oncology, has been published monthly since January 2010. Affiliated with the Japan Society for Neuro-Oncology and the European Association of Neuro-Oncology, it is a global leader in the field. The journal is committed to swiftly disseminating high-quality information across all areas of neuro-oncology. It features peer-reviewed articles, reviews, symposia on various topics, abstracts from annual meetings, and updates from neuro-oncology societies worldwide.